Jones Financial Companies Lllp Has $135,000 Stock Position in Align Technology, Inc. (NASDAQ:ALGN)

Jones Financial Companies Lllp raised its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 60.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 648 shares of the medical equipment provider’s stock after acquiring an additional 245 shares during the quarter. Jones Financial Companies Lllp’s holdings in Align Technology were worth $135,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ALGN. True Wealth Design LLC increased its position in shares of Align Technology by 10,700.0% during the third quarter. True Wealth Design LLC now owns 108 shares of the medical equipment provider’s stock worth $27,000 after buying an additional 107 shares during the period. Neo Ivy Capital Management acquired a new stake in shares of Align Technology during the third quarter worth $32,000. Private Trust Co. NA increased its position in shares of Align Technology by 113.4% during the fourth quarter. Private Trust Co. NA now owns 175 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 93 shares during the period. Versant Capital Management Inc increased its position in shares of Align Technology by 212.2% during the fourth quarter. Versant Capital Management Inc now owns 231 shares of the medical equipment provider’s stock worth $48,000 after buying an additional 157 shares during the period. Finally, Newbridge Financial Services Group Inc. acquired a new stake in shares of Align Technology during the fourth quarter worth $52,000. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Leerink Partnrs upgraded shares of Align Technology from a “hold” rating to a “strong-buy” rating in a report on Monday, January 6th. Leerink Partners upgraded shares of Align Technology from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $235.00 to $280.00 in a report on Monday, January 6th. Mizuho assumed coverage on shares of Align Technology in a report on Wednesday, December 4th. They issued an “outperform” rating and a $295.00 price target for the company. Piper Sandler reduced their price target on shares of Align Technology from $275.00 to $270.00 and set an “overweight” rating for the company in a report on Thursday, February 6th. Finally, Jefferies Financial Group reduced their price target on shares of Align Technology from $285.00 to $260.00 and set a “buy” rating for the company in a report on Thursday, January 23rd. One analyst has rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $269.91.

Align Technology Stock Performance

Shares of ALGN stock opened at $166.20 on Friday. The firm has a market cap of $12.23 billion, a price-to-earnings ratio of 29.63, a P/E/G ratio of 2.24 and a beta of 1.69. Align Technology, Inc. has a 52 week low of $158.13 and a 52 week high of $335.40. The firm’s 50-day simple moving average is $203.61 and its two-hundred day simple moving average is $218.87.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a return on equity of 13.84% and a net margin of 10.54%. Analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.